Hear from and meet with the leading figures in precision oncology to explore how companies are innovating in precision medicine, digital pathology and molecular testing to accelerate timelines and reduce risk in drug development, with in-depth consideration of the latest multiplexed and cytometry tools impacting biomarker research & validation.
Expand your knowledge & discuss future priorities in:
– Molecular Analysis, Multi-Cancer Early Detection and Testing, Companion Diagnostic Development
– Biomarkers for Clinical Development and Personalised Patient Treatment
& much more!
View the agenda here – https://www.oxfordglobal.co.uk/precision-oncology/agenda/download-agenda/?utm_source=ascb&utm_medium=eventlisting&utm_campaign=biomarkers&utm_content=preonc2023
Co-located with Biomarkers Europe 2023 and Targets and Cell Types 2023, attendees will receive access to all three events. For more information contact email@example.com